|
1
|
Landt M, Ludbrook PA and Billadello JJ:
Role of protein binding in renal elimination of leptin. Clin
Endocrinol (Oxf). 59:44–48. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yao H, Cai ZY and Sheng ZX: NAC attenuates
adriamycin-induced nephrotic syndrome in rats through regulating
TLR4 signaling pathway. Eur Rev Med Pharmacol Sci. 21:1938–1943.
2017.PubMed/NCBI
|
|
3
|
Daschner M, Tönshoff B, Blum WF, Englaro
P, Wingen AM, Schaefer F, Wühl E, Rascher W and Mehls O: European
Study Group for Nutritional Treatment of Chronic Renal Failure in
Childhood: Inappropriate elevation of serum leptin levels in
children with chronic renal failure. J Am Soc Nephrol. 9:1074–1079.
1998.PubMed/NCBI
|
|
4
|
Yoshida T, Momotani N, Hayashi M, Monkawa
T, Ito K and Saruta T: Serum leptin concentrations in patients with
thyroid disorders. Clin Endocrinol (Oxf). 48:299–302. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bakr A, Shokeir M, El-Chenawi F,
El-Husseni F, Abdel-Rahman A and El-Ashry R: Tumor necrosis
factor-alpha production from mononuclear cells in nephrotic
syndrome. Pediatr Nephrol. 18:516–520. 2003.PubMed/NCBI
|
|
6
|
Florian M, Florianova L, Hussain S and
Magder S: Interaction of estrogen and tumor necrosis factor alpha
in endothelial cell migration and early stage of angiogenesis.
Endothelium. 15:265–275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matsumoto K and Kanmatsuse K: Elevated
interleukin-18 levels in the urine of nephrotic patients. Nephron.
88:334–339. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Drewe E, McDermott EM and Powell RJ:
Treatment of the nephrotic syndrome with etanercept in patients
with the tumor necrosis factor receptor-associated periodic
syndrome. N Engl J Med. 343:1044–1045. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reinehr T, Kratzsch J, Kiess W and Andler
W: Circulating soluble leptin receptor, leptin, and insulin
resistance before and after weight loss in obese children. Int J
Obes. 29:1230–1235. 2005. View Article : Google Scholar
|
|
10
|
Lányi E, Csernus K, Erhardt E, Tóth K,
Urbán B, Lénárd L and Molnár D: Plasma levels of acylated ghrelin
during an oral glucose tolerance test in obese children. J
Endocrinol Invest. 30:133–137. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schroth M, Kratzsch J, Gröschl M, Rauh M,
Rascher W and Dötsch J: Increased soluble leptin receptor in
children with nephrotic syndrome. J Clin Endocrinol Metab.
88:5497–5501. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schroth M, Gröschl M, Dörr HG, Blum WF,
Rascher W and Dötsch J: Renal loss of leptin in patients with
nephrotic syndrome. Eur J Endocrinol. 145:463–468. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia GE, Xia Y, Ku G, Johnson RJ, Wilson
CB and Feng L: IL-18 translational inhibition restricts IFN-gamma
expression in crescentic glomerulonephritis. Kidney Int.
64:160–169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nguyen MT and Devarajan P: Biomarkers for
the early detection of acute kidney injury. Pediatr Nephrol.
23:2151–2157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Washburn KK, Zappitelli M, Arikan AA,
Loftis L, Yalavarthy R, Parikh CR, Edelstein CL and Goldstein SL:
Urinary interleukin-18 is an acute kidney injury biomarker in
critically ill children. Nephrol Dial Transplant. 23:566–572. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Araya C, Diaz L, Wasserfall C, Atkinson M,
Mu W, Johnson R and Garin E: T regulatory cell function in
idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol.
24:1691–1698. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wakkach A, Augier S, Breittmayer JP,
Blin-Wakkach C and Carle GF: Characterization of IL-10-secreting T
cells derived from regulatory CD4+CD25+ cells
by the TIRC7 surface marker. J Immunol. 180:6054–6063. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barrat FJ, Cua DJ, Boonstra A, Richards
DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL,
Hawrylowicz CM and O'Garra A: In vitro generation of interleukin
10-producing regulatory CD4(+) T cells is induced by
immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and
Th2-inducing cytokines. J Exp Med. 195:603–616. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kiliś-Pstrusińska K, Medyńska A, Zwolińska
D and Wawro A: Interleukin-18 in urine and serum of children with
idiopathic nephrotic syndrome. Kidney Blood Press Res. 31:122–126.
2008. View Article : Google Scholar : PubMed/NCBI
|
